All Stories

  1. PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
  2. The role of antifungals in the management of patients with severe asthma
  3. OUP accepted manuscript
  4. Anti-fungal activity of a novel triazole, PC1244, against emerging azole-resistant Aspergillus fumigatus and other species of Aspergillus
  5. In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris
  6. Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection
  7. 1335. Safety and Pharmacokinetic Profile of PC786, a Novel Inhibitor of Respiratory Syncytial Virus L-protein Polymerase, in a Single and Multiple-Ascending Dose Study in Healthy Volunteer and Mild Asthmatics
  8. Anti-viral efefcts of a Novel RSV polymerase inhibitor, PC786, on primary airrway epithelial cells.
  9. Current approaches to the discovery of novel inhaled medicines
  10. In VitroandIn VivoEfficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, onAspergillus fumigatusInfection
  11. Reply to Rojas, “The Imperative Authentication of Cell Lines”
  12. Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice
  13. A novel inhaled RSV polymerase inhibitor, PC786, on RSV infection
  14. In Vivo Biomarker Analysis of the Effects of Intranasally Dosed PC945, a Novel Antifungal Triazole, on Aspergillus fumigatus Infection in Immunocompromised Mice
  15. Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis
  16. In Vitro and In Vivo Antifungal Profile of a Novel and Long-Acting Inhaled Azole, PC945, on Aspergillus fumigatus Infection
  17. NDP52 inhibition rescues cigarette smoke mediated impairment of autophagy in macrophages
  18. LATE-BREAKING ABSTRACT: Effects of a single treatment with PC786, a novel inhibitor of respiratory syncytial virus replication, on viral load and biomarkers in fully differentiated human bronchial epithelial cells
  19. Recurrent cigarette smoke exposure impairs SIRT1 shuttling in bronchial epithelial cells
  20. Faculty of 1000 evaluation for Activated mouse eosinophils protect against lethal respiratory virus infection.
  21. Inflammation to Pulmonary Diseases
  22. In Vivo Biomarker Analysis of Intranasally Dosed PC945, a Novel Antifungal Agent, in Aspergillus Fumigatus Infection in Immunocompromised Mice
  23. Anti-Viral Activities of PC786, a Novel Inhibitor of Respiratory Syncytial Virus L-Protein Polymerase
  24. STOP accelerating lung aging for the treatment of COPD
  25. Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients
  26. 60 Effects of RV568, a novel narrow spectrum kinase inhibitor, on pro-inflammatory cytokine production in epithelial cells isolated from patients with cystic fibrosis
  27. 89 Superior effects of RV568, a narrow spectrum kinase inhibitor, on RSV infection in primary bronchial epithelial cells obtained from patients with cystic fibrosis
  28. Effects Of RV568, A Narrow Spectrum Kinase Inhibitor, On Human Rhinovirus Replication And Cytokine Production
  29. C13 Corticosteroids
  30. Faculty of 1000 evaluation for Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase.
  31. Fluticasone Furoate, A Novel Enhanced-affinity Inhaled Corticosteroid (ICS), Has Superior Anti-inflammatory Effects Compared To Fluticasone Propionate Under Conditions Of Oxidative Stress
  32. Targeting Th2 Cells in Asthmatic Airways
  33. Peroxynitrite Elevation in Exhaled Breath Condensate of COPD and Its Inhibition by Fudosteine
  34. Nitric Oxide
  35. COPD as a Disease of Accelerated Lung Aging
  36. Differential Flow Analysis of Exhaled Nitric Oxide in Patients With Asthma of Differing Severity
  37. New Insights into the Molecular Mechanisms of Corticosteroids Actions
  38. Glucocorticoid Receptor Nuclear Translocation in Airway Cells after Inhaled Combination Therapy
  39. Histone Acetylation and Histone Deacetylation
  40. Histone Acetylation and Histone Deacetylation
  41. Corticosteroids
  42. Steroid-Sparing Strategies: Other Combinations